menu
    • menu

    Company profile for Bicycle Therapeutics

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We were founded in 2009 based on innovative science conducted in the laboratory of Sir Greg Winter, a pioneer in monoclonal antibodies, to translate our first-in-class Bicycles into transformative medicines for life-altering diseases. We are a transatlantic company, with headquarters in Cambridge, U.K., and many key functions and members of our leadership team located in the biotech hub of Boston, Mass.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bicycle Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    B900, Babraham Research Campus Cambridge, U.K. CB22 3AT
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bicycletherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bicycle-therapeutics/?originalSubdomain=in
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/bicycle_tx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bicycle Therapeutics to Share Duravelo-2 Data at ASCO 2026
    Bicycle Therapeutics to Share Duravelo-2 Data at ASCO 2026

    21 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260521033084/en/Bicycle-Therapeutics-to-Present-Initial-Duravelo-2-Data-at-2026-ASCO-Annual-Meeting

    BUSINESSWIRE
    21 May 2026
    Share Share
    Bicycle Therapeutics Presents At 2026 ASCO Annual Meeting
    Bicycle Therapeutics Presents At 2026 ASCO Annual Meeting

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7196395

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    Bicycle Pharma Updates Nuzefatide Pevedotin, EphA2 Pipeline
    Bicycle Pharma Updates Nuzefatide Pevedotin, EphA2 Pipeline

    20 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-20/bicycle-therapeutics-provides-update-on-nuzefatide-pevedotin-and-epha2-pipeline-at-the-aacr-annual-m

    PHARMIWEB
    20 Apr 2026
    Share Share
    Bicycle Therapeutics Presents At AACR Annual Meeting 2026
    Bicycle Therapeutics Presents At AACR Annual Meeting 2026

    18 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-18/bicycle-therapeutics-announces-oral-and-poster-presentations-at-the-aacr-annual-meeting-2026

    PHARMIWEB
    18 Mar 2026
    Share Share
    Bicycle Downsizes By 30% After Deprioritizing Lead Program
    Bicycle Downsizes By 30% After Deprioritizing Lead Program

    18 Mar 2026

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    18 Mar 2026
    Share Share
    Bicycle Therapeutics Reports Q4 Progress and 2025 Guidance
    Bicycle Therapeutics Reports Q4 Progress and 2025 Guidance

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317342933/en/Bicycle-Therapeutics-Reports-Recent-Business-Progress-and-Fourth-Quarter-and-Full-Year-2025-Financial-Results

    BUSSINESSWIRE
    17 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search